Author:
Hussain Syed A.,Birtle Alison,Crabb Simon,Huddart Robert,Small Diane,Summerhayes Maxwell,Jones Robert,Protheroe Andrew
Subject
Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery
Reference50 articles.
1. Immunotherapy for bladder cancer;Fuge;Res Rep Urol,2015
2. Bladder cancer: ESMO practice guidelines for diagnosis, treatment and follow-up†;Bellmunt;Ann Oncol,2014
3. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987;Bellmunt;J Clin Oncol,2012
4. Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,1999
5. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献